Rockwell Medical, Inc.
NASDAQ: RMTI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark Strobeck
- Employees
- 244
- Headquarters
- Wixom, United States
- IPO year
- 1998
- Market cap
- $26.8M
- Website
- https://www.rockwellmed.com
Loading RMTI…
Loading profile data…Frequently asked questions about RMTI
What does Rockwell Medical, Inc. (RMTI) do?
Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States...
Where does RMTI trade?
Rockwell Medical, Inc. (RMTI) trades on the NASDAQ Capital Market.
What sector is RMTI in?
Rockwell Medical, Inc. (RMTI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Rockwell Medical, Inc.?
Mark Strobeck is the chief executive officer of Rockwell Medical, Inc. (RMTI).
Where is Rockwell Medical, Inc. headquartered?
Rockwell Medical, Inc. is headquartered in United States.
Does RMTI pay a dividend?
Rockwell Medical, Inc. (RMTI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RMTI go public?
Rockwell Medical, Inc. (RMTI) completed its initial public offering in 1998.